CRIS Current Research Information System

BRODOSI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.427
NA - Nord America 3.968
EU - Europa 2.294
SA - Sud America 219
AF - Africa 209
Continente sconosciuto - Info sul continente non disponibili 207
OC - Oceania 2
Totale 11.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.858
SG - Singapore 1.195
CN - Cina 1.065
VN - Vietnam 947
IT - Italia 609
HK - Hong Kong 372
GB - Regno Unito 326
SE - Svezia 285
DE - Germania 283
IN - India 204
FR - Francia 179
KR - Corea 167
BR - Brasile 157
BD - Bangladesh 131
NL - Olanda 128
FI - Finlandia 99
IE - Irlanda 89
RU - Federazione Russa 86
JP - Giappone 78
CA - Canada 57
ZA - Sudafrica 53
CI - Costa d'Avorio 43
SC - Seychelles 43
PH - Filippine 39
BG - Bulgaria 35
ID - Indonesia 34
UA - Ucraina 28
JO - Giordania 27
NG - Nigeria 25
PL - Polonia 23
TH - Thailandia 23
TR - Turchia 23
AR - Argentina 21
AT - Austria 21
PK - Pakistan 21
CH - Svizzera 20
MX - Messico 19
TG - Togo 19
GR - Grecia 18
IQ - Iraq 17
BE - Belgio 15
SA - Arabia Saudita 14
TW - Taiwan 14
ES - Italia 13
MY - Malesia 13
EC - Ecuador 11
IR - Iran 11
CR - Costa Rica 9
EE - Estonia 9
LT - Lituania 9
CO - Colombia 8
EG - Egitto 8
CL - Cile 6
HN - Honduras 6
JM - Giamaica 6
PE - Perù 6
RO - Romania 6
YE - Yemen 6
NP - Nepal 5
AZ - Azerbaigian 4
LB - Libano 4
PY - Paraguay 4
AO - Angola 3
DZ - Algeria 3
ET - Etiopia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LY - Libia 2
MA - Marocco 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
DM - Dominica 1
GH - Ghana 1
GP - Guadalupe 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
Totale 11.116
Salva come PNG Salva come JPEG
Città #
Singapore 837
Ashburn 519
Hong Kong 352
Hefei 345
San Jose 263
Southend 240
Chandler 233
Hanoi 220
Ho Chi Minh City 214
Santa Clara 198
Seoul 151
Fairfield 150
Dallas 140
Council Bluffs 138
Bologna 137
Los Angeles 115
Beijing 111
Boardman 100
Princeton 97
Seattle 91
Dublin 89
Helsinki 84
Houston 83
Woodbridge 77
Lauterbourg 65
Dong Ket 63
New York 61
Wilmington 59
Milan 57
Tokyo 56
Redmond 53
Ann Arbor 49
Cambridge 49
Abidjan 43
Rome 41
Bengaluru 40
Johannesburg 36
Buffalo 34
Munich 34
Sofia 34
Frankfurt am Main 33
São Paulo 33
Da Nang 31
Redondo Beach 31
Haiphong 29
Guangzhou 28
Turin 26
Abeokuta 25
Amman 25
Des Moines 25
Berlin 24
Shanghai 24
Medford 23
San Diego 23
London 21
Clifton 20
Lomé 19
Phoenix 19
Brooklyn 18
Montreal 17
Westminster 17
Jakarta 16
Amsterdam 15
Atlanta 15
Brussels 15
Piscataway 15
Warsaw 15
Falkenstein 13
Jinan 13
Orem 13
Padova 13
Paris 13
Chicago 12
Düsseldorf 12
Florence 12
Kuala Lumpur 12
Lappeenranta 12
Naples 12
Parma 12
San Francisco 12
Tongling 12
Dhaka 11
Hyderabad 11
Hải Dương 11
Jacksonville 11
Nanjing 11
North Bergen 11
Nuremberg 11
Rimini 11
Vienna 11
Zhengzhou 11
Biên Hòa 10
Denver 10
Mexico City 10
Philadelphia 10
Bangkok 9
Bern 9
Chennai 9
Istanbul 9
Miami 9
Totale 6.728
Salva come PNG Salva come JPEG
Nome #
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers 281
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 250
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 247
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 233
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 230
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 229
Management of non-alcoholic fatty liver disease 226
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 223
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 222
Long-term weight loss maintenance for obesity: A multidisciplinary approach 214
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) 210
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 202
Pegvaliase therapy for phenylketonuria: Real-world case series and clinical insights 201
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 201
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 195
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 195
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 193
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 182
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 180
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 180
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 180
NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report 175
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 172
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 170
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? 170
CD 133+ stem cells for the treatment of end stage liver disease. 165
Fatty liver in pregnancy: a narrative review of two distinct conditions 165
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity 162
A cross-sectional study on the prevalence of eating disorders in liver transplanted patients with type 2 diabetes and/or overweight/obesity 158
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 157
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 156
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background 150
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 150
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 150
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 146
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction 144
Malnutrition in hospitalized patients with SARS-CoV-2 infection 139
Obesity and NAFLD: Same problem? 136
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 132
The treatment of diabetes in advanced liver disease: change of a paradigm 131
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 131
Bone marrow derived stem cells for the treatment of end-stage liver disease. 129
COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs 128
Effect of physical exercise on postural control in diabetic subjects 123
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 122
NASH: A glance at the landscape of pharmacological treatment 118
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 118
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 118
Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza 114
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 112
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients 111
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial 110
CD133+ stem cells for the treatment of end-stage liver disease 108
The management of transitional care of patients affected by phenylketonuria in Italy: Review and expert opinion 107
Exercise-induced changes in postural stability among patients with diabetes 104
Effects of physical exercise on autonomic control in diabetic patients. 104
Relationship Between Physical Activity and Autonomic Responses in Adults with Type 2 Diabetes 104
'Effect of exercise training on postural control in people with diabetes 103
Web-based counseling for NAFLD. Final results. 100
Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey 99
Impact of exercise training on postural control in people with diabetes. 97
Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion) 94
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial 90
Effects of Physical Activity Level on Microsaccade Dynamics During Optic Flow Stimulation in Adults with Type 2 Diabetes 85
Benefits of a prolonged-release amino acid mixture in four pregnant women with phenylketonuria 83
Night eating syndrome in liver transplant recipients with diabetes or excess-weight: a cross-sectional study 81
Effect of six months of exercise program on eye movements of diabetic people. 78
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 71
Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: taking-up a challenge for the hepatologist. 71
NAFLD, the hepatic manifestation of the metabolic syndrome 70
Hepatitis C recurrence after liver transplantation: do patients with mild disease need to be treated? 68
Impact of exercise protocol on postural control in people with diabetes 67
The role of physical activity on autonomic functions in diabetic patients 67
A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD). 66
A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) 65
Seven score systems to evaluate candidates to orthotopic liver transplantation: which is the winner? 63
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes 62
Motor control evaluation in diabetic subjects 61
Transition in inherited metabolic diseases: the dietitians, pediatricians and adult physicians’ point of view: the results of an Italian survey 60
Lifetime physical activity and autonomic responses in adults with type 2 diabetes 58
Natremia and Child-Turcotte-Pugh (CTP) score may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD) 57
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study 54
Natremia and Child-Turcotte-Pugh (CTP) may improve the selection of candidates for liver transplantation (LT) with lower model for end-stage liver disease score (MELD). 50
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 23
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders 19
null 1
Totale 11.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.349
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022891 0 117 48 57 81 38 18 56 40 64 238 134
2022/20231.011 85 116 56 127 86 106 40 33 203 30 65 64
2023/2024463 42 69 33 43 35 83 14 48 18 39 13 26
2024/20251.966 77 230 172 190 254 71 117 74 52 151 146 432
2025/20265.570 446 499 483 466 483 243 638 202 988 422 434 266
2026/2027414 202 212 0 0 0 0 0 0 0 0 0 0
Totale 11.326